Isabel Graupera
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 112 publications
The role of endoscopic therapies for patients with metabolic dysfunction-associated steatotic liver disease (MASLD).
Journal: Expert review of gastroenterology & hepatology
Published: February 13, 2026
Liver stiffness dynamics in European populations (LiverScreen): a longitudinal, multicentre, prospective, population-based cohort study.
Journal: The lancet. Gastroenterology & hepatology
Published: January 05, 2026
The rate and predictors of recompensation in patients with decompensated cirrhosis due to metabolic dysfunction-associated liver disease (MASLD).
Journal: Hepatology communications
Published: December 11, 2025
Hepatic venous pressure gradient, non-invasive tests, and prognosis across the subtypes of advanced steatotic liver disease.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: December 11, 2025
Hepatic Venous Pressure Gradient, Noninvasive Tests, and Prognosis Across the Subtypes of Advanced Steatotic Liver Disease.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: December 11, 2025
Prevalence of liver fibrosis in the general population (the LiverScreen project): a multinational European cohort study.
Journal: Lancet (London, England)
Published: September 17, 2025
Cholesterol-responsive NFE2L1-INSIG1 interaction controls VLDL secretion and metabolic dysfunction-associated steatohepatitis pathogenesis in mice.
Journal: The Journal of clinical investigation
Published: June 30, 2025
PD-L1 and the risk of bacterial infection in patients with chronic liver diseases: An international multicohort study.
Journal: JHEP reports : innovation in hepatology
Published: June 28, 2025
LiverRisk score (LRS) predicts long-term liver-related outcomes in a cohort of Veterans without evidence of liver disease.
Journal: Hepatology (Baltimore, Md.)
Published: May 14, 2025
Marked Variation in Hepatic Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease Over 5 Years: A Community-Based Study Using Controlled Attenuation Parameter.
Journal: United European gastroenterology journal
Published: March 21, 2025
Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical Trial.
Journal: JAMA
Published: February 05, 2025
Autoantibodies are associated with worse outcomes in MASLD.
Journal: JHEP reports : innovation in hepatology
Published: January 29, 2025
Last Updated: 09/26/2026